Описание
Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage.
Figure 10
ChartSource Paper
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.Cite This Figure
![Figure 10: Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage.]() > Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." *International journal of molecular sciences*, 2024. PMID: [38673787](https://pubmed.ncbi.nlm.nih.gov/38673787/)
<figure> <img src="" alt="Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage." /> <figcaption>Figure 10. Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage.<br> Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38673787/">38673787</a></figcaption> </figure>